Crinetics Pharmaceuticals (CRNX) Non-cash Items (2018 - 2025)

Crinetics Pharmaceuticals' Non-cash Items history runs 8 years deep, the most recent figure standing at $81.3 million for Q2 2025.

• In Q2 2025, Non-cash Items rose 1302.03% year-over-year to $81.3 million; the TTM figure through Jun 2025 stood at $81.3 million (up 1302.03% YoY), while the FY2024 annual figure was $6.5 million, up 23.27% from the prior year.
• Non-cash Items was $81.3 million for Q2 2025 at Crinetics Pharmaceuticals, down from $136.4 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $4.1 billion in Q4 2022 to a low of $2575.0 in Q2 2021.
• Historically, Non-cash Items has averaged $261.7 million across 5 years, with a median of $10.4 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Non-cash Items surged 132214.25% in 2022, then plunged 99.87% in 2023.
• A 5-year view of Non-cash Items shows it stood at $43.4 million in 2021, then jumped by 9399.11% to $4.1 billion in 2022, then slumped by 99.87% to $5.3 million in 2023, then increased by 23.27% to $6.5 million in 2024, then soared by 1154.48% to $81.3 million in 2025.
• The last three Non-cash Items figures came in at $81.3 million (Q2 2025), $136.4 million (Q1 2025), and $6.5 million (Q4 2024), per Business Quant data.